drugset / Trial / NCT04183205
Predicting SSRI Efficacy in Veterans With PTSD
Phase 4
Terminated
19 enrolled
VA Office of Research and Development
Massachusetts General Hospital · collabMiddlebury College · collabRalph H. Johnson VA Medical Center · collab
Non-randomizedSequentialDouble-blindScreening
Summary
This is a research study to examine the effectiveness of a brief screening method that may predict which people with posttraumatic stress disorder (PTSD) or depression are most likely to show a positive response to selective serotonin reuptake inhibitor (SSRI) medications. Participants will be recruited over approximately 5.25 years, until at least 94 participants complete the 17 week study.
Timeline
- Start
- 2019-09-11
- Primary completion
- 2025-03-30
- Completion
- 2025-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sertraline | Small molecule | 50 mg | — |
| Comparator | Sertraline | Small molecule | 200 mg | — |